Viridos Stock
Industrial and TransportationLooking to sell Viridos stock or options?
Viridos develops genomic-driven technology aimed at tackling global energy and environmental issues. The company's technology prioritizes bio-based production, enhancing existing biological production hosts, and creating new synthetic hosts. This enables academic and commercial R&D organizations to efficiently produce pharmaceuticals, vaccines, and nutritional and bio-industrial products from renewable biological resources.
Investors Include:
Greg Bisconti, CONNECT (San Diego), United States Department of War, Donald Braun, The Meteor Group, Genting Genomics, Breakthrough Energy, United Therapeutics, U.S. Department of Energy, Invitrogen.